All posts by Genetic Signatures

Dr. Damien Stark of (St. Vincent’s Pathology Sydney), presenting at upcoming NRL Workshop on Molecular Diagnostics, 15-16th October Melbourne, Australia

By | Latest News | No Comments

Genetic Signatures EasyScreen™ Pathogen Detection Kits will be featured in an oral presentation at the upcoming National Reference Laboratory (NRL) Workshop on Molecular Diagnostics in Melbourne, Australia.

Dr. Damien Stark from St. Vincent’s Hospital Pathology (SydPath) will present “EasyScreen™ Multiplex PCR for STI Infections, a Year in Review.”

The aim of this workshop is to focus specifically on molecular techniques involved in detecting infectious pathogens. NRL has invited guest speakers who will offer valuable insight into their area of expertise and also welcomes those working in the industry to share their experience through a presentation by way of abstract submission. This Workshop will allow you to connect with your peers and keep you updated on the advances in this field as the industry continues to develop and expand at a rapid rate.

Visit the NRL website for more information.

For more information click the LINK

NRL-Workshop-2018

 

Genetic Signatures exhibiting at ESCV 2018 Athens, Greece, 23-26 September

By | Latest News | No Comments

Genetic Signatures are exhibiting at the 21st ESCV (European Society for Clinical Virology) in Athens, Greece, 23-26 September 2018.

The ESCV Annual Meeting has been a major event for the Clinical Virology scientific community and it is becoming more popular, comprehensive, innovative and influential while maintaining high standards of scientific quality and a family atmosphere. The 21st ESCV Annual Meeting is promising to be an exciting event, covering all timely topics of Clinical Virology, enabling delegates to exchange knowledge with world’s leading experts, network with colleagues and discuss the latest advances on “traditional” and emerging viruses.

Visit Genetic Signatures at Booth 3A at ESCV 2018 for more information.

Click the link to visit the ESCV website for more information: ESCV 2018

 

ESCV

Genetic Signatures exhibiting at the upcoming Sheffield Microbe 2018 Symposium, 21-23 September in Sheffield, UK.

By | Latest News | No Comments

Since the first Sheffield Microbe in 1986, Sheffield Microbe has provided high quality, value for money, and symposia for local and national Biomedical Scientists. In recent years Microbe has attracted delegates from around the world, and is regularly attended by delegates across Europe. There are currently fifteen committee organisers who organise forthcoming Microbe events. Microbe symposia are held every 2 years.

Microbe events follow a well-proven routine, involving a mixture of current topics and lectures for Biomedical Scientists in Microbiology and related disciplines. Also included is an often oversubscribed Trade Exhibition and Social Programme.

Visit the website for more information: Sheffield Microbe 2018

Genetic Signatures’ CEO Dr. John Melki interview by Proactive Investors

By | ASX Announcements, Latest News | No Comments

Genetic Signatures’ CEO Dr. John Melki was recently interviewed by Proactive investors at the ASX Small and Mid-Cap Conference.

See the link below to learn more about our 3baseTM technology and EasyScreenTM assays, and how we’re improving patient outcomes.

For more information click the link:  Genetic Signatures’ clinical trials demonstrate product efficacy.

Genetic Signatures’ CEO Dr. John Melki presenting at the inaugural ASX Small and Mid-Cap Conference 6th September, Sydney, Australia.  

By | ASX Announcements, Latest News | No Comments

Join ASX for the inaugural ASX Small and Mid-Cap Conference, showcasing emerging leaders in the small and mid-cap category. This is a unique opportunity to hear from a broad range of ASX-listed companies and their CEOs in the comfortable surrounds of the International Convention Centre at Darling Harbour.

This conference aims to welcome over 400 attendees from the finance industry, with an emphasis on SMSF / sophisticated investors.

Visit John and the team to learn more about the directions of Genetic Signatures.

For more information click here